Akila Viswanathan, M.D., executive vice chair of Johns Hopkins Radiation Oncology and Molecular Radiation Sciences, was part of a panel discussion on the rise of HPV-related cancers. The panel was just one section of the Washington Post Cancer Summit. Viswanathan was joined by other experts in taking look at rising HPV-related cancer rates in the(...)
Prevention/Screening
A Look Inside the Kimmel Cancer Center’s Cancer Medicine Cabinet
Posted by | Issues & Perspectives, Patient Stories, Prevention/Screening, Research, treatmentRead the latest issue of Promise & Progress featuring research advances in cancer drug discovery and development, promising new cancer drugs, patient stories and more. From scientific meetings to our own dinner tables, conversations about better treatments for cancer are among the most frequently discussed health care topics. Everyone wants them—the doctors and scientists who(...)
“SEEK” and You May Find Cancer
Posted by | precision medicine, Prevention/Screening, Research, treatmentThe team of cancer genetics experts that deciphered the genetic blueprints of cancer, have developed two new screening tests that have the promise to detect cancer in an early and curable stage. As the names of the tests indicate PapSEEK and UroSEEK, they seek out and find genetic evidence of cancer by detecting DNA released(...)
Early-Stage Prostate Cancer: To Treat or Not to Treat
Posted by | Prevention/ScreeningProstate cancer is a leading health problem for men. As strategies for prostate cancer screening and active surveillance are refined, men may benefit from early detection and cure of life-threatening prostate cancer but avoid overtreatment of the non-life-threatening variety. Read Kimmel Cancer Center director William Nelson’s editorial in Cancer Today, a publication of the American(...)
New Test Detects Eight Cancer Types
Posted by | Prevention/Screening, Research, treatmentMay make the most feared disease a little less scary Cancer is scary. Part of the reason—maybe even the main reason—cancer is so scary, is that it seems to come out of nowhere and changes lives in the blink of an eye. We’re feeling fine, but under the surface, hidden within the DNA of our(...)
Differences and Disparities in Cancer
Posted by | Issues & Perspectives, Prevention/ScreeningThe good news is that there is an ongoing 1.5 percent annual decline in cancer death rates. The more troubling news is that cancer does not affect all equally. Read Kimmel Cancer Center director William Nelson’s editorial in Cancer Today, a publication of the American Association for Cancer Research.
A New Issue of Breast Matters
Posted by | Patient Stories, precision medicine, Prevention/Screening, Research, Survivorship, treatmentThe latest issue of Breast Matters is now out on newsstands, and we have it here for you in our brand new digital design. The new issue includes news on our GAITWAY Tumor board, a group of more than a dozen experts who match treatments to the unique genetic characteristics of patients’ tumors. It also(...)
Cancer Screening Tests to Consider Throughout Life
Posted by | Prevention/ScreeningAt a certain age, you might start to wonder if you should be stepping up your screening for cancer. And then you might start to wonder: what exactly is that age? And what kinds of cancer screening should I consider? While there are some guidelines to these questions, there has to be a lot of(...)
What should you think about before getting a mammogram?
Posted by | Prevention/ScreeningA frequent question women ask Susan Harvey, M.D. about mammograms: “Can’t you make it so they don’t squeeze so hard?” Unfortunately, some discomfort is part of the screening, as breast imagers “compress the breast to get the best quality image,” says Harvey, director of the Johns Hopkins Breast Imaging Division in the Department of Radiology.(...)
What is PSA?
Posted by | Prevention/Screening“PSA, or prostate specific antigen, is an enzyme that normally appears in the ejaculate or central reproduction but when there’s a cancer present, it leaks into the circulation system so you can detect it in the bloodstream, where it becomes a marker of prostate cancer and other prostate diseases,” explains William G. Nelson, M.D., Ph.D.,(...)